Cargando…

The Advisory Committee on Immunization Practices’ Interim Recommendation for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020

Detalles Bibliográficos
Autores principales:	Dooling, Kathleen, McClung, Nancy, Chamberland, Mary, Marin,, Mona, Wallace, Megan, Bell, Beth P., Lee, Grace M., Talbot, H. Keipp, Romero, José R., Oliver, Sara E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Centers for Disease Control and Prevention 2020
Materias:	Full Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737687/ https://www.ncbi.nlm.nih.gov/pubmed/33301429 http://dx.doi.org/10.15585/mmwr.mm6949e1

Ejemplares similares

The Advisory Committee on Immunization Practices’ Updated Interim Recommendation for Allocation of COVID-19 Vaccine — United States, December 2020
por: Dooling, Kathleen, et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine — United States, 2020
por: McClung, Nancy, et al.
Publicado: (2020)

The Advisory Committee on Immunization Practices’ Ethical Principles for Allocating Initial Supplies of COVID-19 Vaccine—United States, 2020
por: McClung, Nancy, et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Moderna COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020
por: Oliver, Sara E., et al.
Publicado: (2020)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Janssen COVID-19 Vaccine — United States, February 2021
por: Oliver, Sara E., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendations for Additional Primary and Booster Doses of COVID-19 Vaccines — United States, 2021
por: Mbaeyi, Sarah, et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Children Aged 5–11 Years — United States, November 2021
por: Woodworth, Kate R., et al.
Publicado: (2021)

The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine in Adolescents Aged 12–15 Years — United States, May 2021
por: Wallace, Megan, et al.
Publicado: (2021)

Interim Recommendations from the Advisory Committee on Immunization Practices for the Use of Bivalent Booster Doses of COVID-19 Vaccines — United States, October 2022
por: Rosenblum, Hannah G., et al.
Publicado: (2022)

Interim Recommendation of the Advisory Committee on Immunization Practices for Use of the Novavax COVID-19 Vaccine in Persons Aged ≥18 years — United States, July 2022
por: Twentyman, Evelyn, et al.
Publicado: (2022)

Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine: Updated Interim Recommendations from the Advisory Committee on Immunization Practices — United States, December 2021
por: Oliver, Sara E., et al.
Publicado: (2022)

Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Krow-Lucal, Elisabeth, et al.
Publicado: (2022)

Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
por: Dooling, Kathleen L., et al.
Publicado: (2018)

Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013
por: Keitel, Wendy, et al.
Publicado: (2013)

Use of Respiratory Syncytial Virus Vaccines in Older Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023
por: Melgar, Michael, et al.
Publicado: (2023)

Commentary: The Advisory Committee on Immunization Practices’ ethical principles for allocating initial supplies of COVID-19 vaccine — United States, 2020
por: Fishman, Jay
Publicado: (2021)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2023–24 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2023)

Use of Ebola Vaccine: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
por: Choi, Mary J., et al.
Publicado: (2021)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021–22 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2021)

Use of Pfizer-BioNTech COVID-19 Vaccine in Persons Aged ≥16 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2021
por: Dooling, Kathleen, et al.
Publicado: (2021)

Updated Framework for Development of Evidence-Based Recommendations by the Advisory Committee on Immunization Practices
por: Lee, Grace, et al.
Publicado: (2018)

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season
por: Grohskopf, Lisa A., et al.
Publicado: (2022)

Cholera Vaccine: Recommendations of the Advisory Committee on Immunization Practices, 2022
por: Collins, Jennifer P., et al.
Publicado: (2022)

Use of Updated COVID-19 Vaccines 2023–2024 Formula for Persons Aged ≥6 Months: Recommendations of the Advisory Committee on Immunization Practices — United States, September 2023
por: Regan, Joanna J., et al.
Publicado: (2023)

Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020
por: Mbaeyi, Sarah A., et al.
Publicado: (2020)

Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020
por: Nelson, Noele P., et al.
Publicado: (2020)

Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
por: MacNeil, Jessica R., et al.
Publicado: (2021)

Interim report on Advisory Mechanisms and Organization
por: Ekelöf, T., et al.
Publicado: (2012)

Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
por: Wong, Karen K., et al.
Publicado: (2017)

Japanese Encephalitis Vaccine: Recommendations of the Advisory Committee on Immunization Practices
por: Hills, Susan L., et al.
Publicado: (2019)

Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Anderson, Tara C., et al.
Publicado: (2022)

Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Persons Experiencing Homelessness
por: Doshani, Mona, et al.
Publicado: (2019)

Recommendations of the COMIMECA following the interim report of the CERN review committee
por: CERN. Geneva
Publicado: (1987)

The Laboratory Advisory Committee
Publicado: (1968)

Inaugural meeting of the malaria policy advisory committee to the WHO: conclusions and recommendations
Publicado: (2012)

Recommendation of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus–Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
por: Marin, Mona, et al.
Publicado: (2018)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2012 meeting
Publicado: (2012)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of March 2013 meeting
Publicado: (2013)

Malaria Policy Advisory Committee to the WHO: conclusions and recommendations of September 2013 meeting
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sbelaf59v89almsgbnjgalaklm